Interdisciplinary Pain Centre, University Hospital Freiburg, Freiburg, Germany.
Pain Physician. 2012 May-Jun;15(3):203-12.
For more than 3 decades, spinal cord stimulation has successfully been employed to treat neuropathic pain. Cervical spinal cord stimulation, despite now being standard in many hospitals, has only rarely been subjected to a critical review within the literature.
The aim of this study was to determine the efficacy of cervical spinal cord stimulation (SCS) in a representative clinical sample. We also wanted to evaluate how factors such as stimulation parameters, unwanted paresthesia of the trunk and legs, and changes in paresthesia status due to head movement and how they affect SCS effectiveness.
Retrospective study.
Academic university interdisciplinary pain center.
We reviewed the records of patients who had been treated at our institution with cervical neurostimulators from November 1, 2001 through October 31, 2011. Information regarding age, gender, diagnosis, age at time of implantation, duration of disease, lead position, hardware in use, revision operations, and stimulation parameters were recorded. In addition, a short telephone interview was conducted, which contained the following items: pain scores on the numeric analog scale (NAS) with and without stimulation, time intervals of stimulation, paresthesia coverage, changes in paresthesia coverage by head movements, unwanted paresthesia of the trunk and legs, treatment satisfaction, and medication intake.
Twenty-three patients were treated. Eighteen patients proceeded to an implantable pulse generator (IPG) implant. In one patient, the system was removed after 4 years despite optimal function, because the patient was no longer experiencing pain. Average NAS pain scores were 6.8 (range 5.5 - 10.0, standard deviation [SD] 1.7) without, and 2.8 (range 0 - 7.5, SD 2.2) with neurostimulation. Fourteen revisions (5 due to lead dislocation, 5 due to lead breakage and 4 IPG revisions) were necessary in 9 of the 18 patients during a mean follow-up of 6.2 years. Most patients reported complete paresthesia coverage. Four patients reported unwanted paresthesia of the trunk or lower limb and 11 patients reported changes in paresthesia with head movements. In both instances, pain reduction was not affected.
Retrospective study.
Cervical spinal cord stimulation appears to be effective in the treatment of neuropathic upper limb pain. Complications are not significantly more frequent than in SCS for lower limb pain. Changes in paresthesia with head movements and unwanted paresthesia did not affect the outcome.
脊髓刺激已成功应用于治疗神经病理性疼痛超过 30 年。尽管颈椎脊髓刺激目前在许多医院中已成为标准治疗方法,但在文献中很少对其进行严格的审查。
本研究旨在确定颈椎脊髓刺激(SCS)在代表性临床样本中的疗效。我们还评估了刺激参数、躯干和腿部的不想要的感觉异常、由于头部运动导致的感觉异常状态的变化以及它们如何影响 SCS 的有效性等因素。
回顾性研究。
学术大学跨学科疼痛中心。
我们回顾了 2001 年 11 月 1 日至 2011 年 10 月 31 日在我院接受颈椎神经刺激器治疗的患者的记录。记录了患者的年龄、性别、诊断、植入时的年龄、疾病持续时间、导线位置、使用的硬件、翻修手术以及刺激参数。此外,还进行了简短的电话访谈,内容包括以下项目:有和无刺激时的数字模拟量表(NAS)疼痛评分、刺激时间间隔、感觉异常覆盖范围、头部运动引起的感觉异常覆盖范围变化、躯干和腿部不想要的感觉异常、治疗满意度和药物摄入。
共治疗了 23 例患者。18 例患者进展为可植入脉冲发生器(IPG)植入。1 例患者尽管功能最佳,但在 4 年后因不再感到疼痛而取出系统。无刺激时的平均 NAS 疼痛评分为 6.8(范围 5.5-10.0,标准差 [SD] 1.7),有刺激时为 2.8(范围 0-7.5,SD 2.2)。18 例患者中的 9 例在平均 6.2 年的随访中需要进行 14 次翻修(5 次因导线脱位,5 次因导线断裂,4 次因 IPG 翻修)。大多数患者报告完全感觉异常覆盖范围。4 例患者报告躯干或下肢不想要的感觉异常,11 例患者报告头部运动时感觉异常变化。在这两种情况下,疼痛减轻均不受影响。
回顾性研究。
颈椎脊髓刺激似乎对治疗神经性上肢疼痛有效。并发症的发生率并不明显高于下肢疼痛的 SCS。头部运动引起的感觉异常变化和不想要的感觉异常并不影响结果。